Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity-Reference-Cited by-同舟云学术

Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity

Published:2016-11 Issue: Volume:13 Page:37-45
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Carlucci Christian,Petrof Elaine O.,Allen-Vercoe Emma

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference103 articles.

1. Clostridium difficile colitis: pathogenesis and host defence;Abt;Nat. Rev. Microbiol.,2016

2. The long-term efficacy and safety of fecal microbiota transplant for recurrent, severe, and complicated Clostridium difficile infection in 146 elderly individuals;Agrawal;J. Clin. Gastroenterol.,2016

3. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea;Antharam;J. Clin. Microbiol.,2013

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of fecal microbiota transplantation for treatment of ulcerative colitis: A post-consensus systematic review and meta-analysis;World Journal of Clinical Cases;2024-07-26

2. Understanding gut microbiome‐based machine learning platforms: A review on therapeutic approaches using deep learning;Chemical Biology & Drug Design;2024-03

3. The gastrointestinal tract and Parkinson’s disease;Frontiers in Cellular and Infection Microbiology;2024-01-15

4. Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies;Translational Neurodegeneration;2023-12-15

5. Host Immune Responses to Clostridioides difficile Infection and Potential Novel Therapeutic Approaches;Tropical Medicine and Infectious Disease;2023-11-23